Dengfei Xu
Overview
Explore the profile of Dengfei Xu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
77
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Jiang C, Xu D, Feng H, Ren Z, Li X, Chen Y, et al.
Discov Oncol
. 2024 Sep;
15(1):465.
PMID: 39298013
The main cause of gastric cancer (GC)-related death is due to malignant cell unregulated distant metastasis and proliferation. Heterogeneous nuclear ribonucleoprotein A1 (hnRNPA1) has been shown to play an important...
2.
Feng H, Xu D, Jiang C, Chen Y, Wang J, Ren Z, et al.
Biomark Res
. 2024 Feb;
12(1):19.
PMID: 38311781
Background: Distant metastasis is the major cause of lung adenocarcinoma (LUAD)-associated mortality. However, molecular mechanisms involved in LUAD metastasis remain to be fully understood. While the role of long non-coding...
3.
Xu D, Feng H, Ren Z, Li X, Jiang C, Chen Y, et al.
Cancer Genomics Proteomics
. 2023 Nov;
20(6suppl):744-753.
PMID: 38035707
Background/aim: Cervical cancer (CC) poses a significant threat to women's health and has a relatively poor prognosis due to local invasion and metastasis. It is, therefore, crucial to elucidate the...
4.
Cui Z, Ruan Z, Li M, Ren R, Ma Y, Zeng J, et al.
Redox Rep
. 2023 Nov;
28(1):2279813.
PMID: 38010093
Objective: Obstructive sleep apnea (OSA) is associated with severity of pneumonia; however, the mechanism by which OSA promotes lung cancer progression is unclear. Methods: Twenty-five lung cancer patients were recruited...
5.
Cui Z, Ruan Z, Li M, Ren R, Ma Y, Zeng J, et al.
Int Immunopharmacol
. 2023 Jul;
122:110652.
PMID: 37478668
Accumulating evidence has shown an increased tumor incidence and reduced survival rate in cancer patients with obstructive sleep apnea (OSA). Although intermittent hypoxia is known to play a crucial role,...
6.
Liu L, Li M, Zhang J, Xu D, Guo Y, Zhang H, et al.
Arch Biochem Biophys
. 2023 Feb;
737:109551.
PMID: 36822388
Docetaxel is a first-line chemotherapy drug for castration-resistant prostate cancer (CRPC); yet, some CRPC patients develop docetaxel drug resistance. Cabazitaxel is approved in the post-docetaxel treatment setting. However, recent studies...
7.
Wang P, Teng L, Feng Y, Yue Y, Han M, Yan Q, et al.
Proc Natl Acad Sci U S A
. 2022 Nov;
119(49):e2208904119.
PMID: 36445966
The protooncoprotein N-Myc, which is overexpressed in approximately 25% of neuroblastomas as the consequence of gene amplification, has long been postulated to regulate DNA double-strand break (DSB) repair in neuroblastoma...
8.
Cui Z, Xu D, Zhang F, Sun J, Song L, Ye W, et al.
Exp Cell Res
. 2021 Jun;
405(2):112677.
PMID: 34111474
Cisplatin (CDDP) is the first generation of platinum-based drug and is widely used to treat many cancers due to its potency. The present study aims to explore the effects of...
9.
Yang C, Yuan H, Gu J, Xu D, Wang M, Qiao J, et al.
Cell Death Discov
. 2021 Jan;
7(1):6.
PMID: 33431858
The development of resistance to anticancer drugs is believed to cause chemotherapy failure in pancreatic cancer (PC). The efflux of anticancer drugs mediated by ATP-binding cassette (ABC) transporters is a...
10.
Xu D, Yuan H, Meng Z, Yang C, Li Z, Li M, et al.
J Cancer
. 2020 Mar;
11(8):2101-2112.
PMID: 32127937
Cadherin 13 (CDH13) is an atypical cadherin that exerts tumor-suppressive effects on cancers derived from epithelial cells. Although the CDH13 promoter is frequently hypermethylated in pancreatic cancer (PC), the direct...